EP0064366A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Pharmaceutical compositions
Assignee: Beecham Group PLC
•
Filing: 1982-04-23
•
Granted: —
•
Expires: 2002-04-23
Abstract
Abstract A pharmaceutical composition, for use in the desensitisation therapy of humans allergic to non-infective allergens, comprises a non-infective allergen and an adjuvant consisting of a C 10-22 alkyl ester of tyrosine or a pharmaceutically acceptable salt thereof.
Inventors
- 👤 Brian George Overell
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-24 10:28
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/35; A61K39/36; A61P; A61P37/00; A61P37/08; A61K2039/555; A61K2039/55511
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
25 words
A pharmaceutical composition comprising a non-infective allergen and an adjuvant which comprises a C 10-22 alkyl ester of tyrosine or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim
25 words
A pharmaceutical composition comprising a non-infective allergen and an adjuvant which comprises a C 10-22 alkyl ester of tyrosine or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
23 words
A composition according to claim 1, in which the alkyl ester is the n-decyl, n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl or n-eicosyl ester of tyrosine.
Claim 4
Dependent Claim
26 words
A composition according to claim 1 or claim 2, in which the non-infective allergen is selected from pollens, weeds, house dust mites, dander and Hymeroptera venoms.
Claim 5
Dependent Claim
13 words
A composition according to claim 1, comprising a non-infective allergen and n-octadecyl tyrosine.
Claim 6
Dependent Claim
14 words
A composition according to claim 4, in which the allergen is rye grass pollen.
Claim 7
Dependent Claim
20 words
A composition according to anyone of claims 1 to 5, in the form of a desensitisation vaccine for allergic humans.
Claim 8
Dependent Claim
31 words
A process for the preparation of a composition according to any one of claims 1 to 6, which comprises bringing into conjunction the allergen and the tyrosine ester or salt thereof.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.